drugset

drugset / Trial / NCT01676571

Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women

NCT01676571 ↗

Phase 1 Completed 16 enrolled H. Lundbeck A/S

NaSingle-groupOpen-labelTreatment

Summary

The rationale for this pharmacokinetic (PK) study is to determine the PK parameters for Lu AA21004 (Vortioxetine) in the Chinese population.

Timeline

Start: 2012-10
Primary completion: 2012-11
Completion: —

Publications

Miao J, Wang G, Hou J, Areberg J, Zhao Y, Hojer AM, Ettrup A. Pharmacokinetics and Safety of Vortioxetine in the Chinese Population. Adv Ther. 2019 Nov;36(11):3134-3146. doi: 10.1007/s12325-019-01092-4. Epub 2019 Sep 24.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vortioxetine	Unknown	10 mg	Oral

Indications

No indication recorded.